Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Operating Margin (2022 - 2023)

Historic Operating Margin for Pasithea Therapeutics (KTTA) over the last 2 years, with Q2 2023 value amounting to 1100.81%.

  • Pasithea Therapeutics' Operating Margin rose 181287000.0% to 1100.81% in Q2 2023 from the same period last year, while for Mar 2024 it was 4832.43%, marking a year-over-year decrease of 15118100.0%. This contributed to the annual value of 2587.35% for FY2022, which is 273383800.0% up from last year.
  • Pasithea Therapeutics' Operating Margin amounted to 1100.81% in Q2 2023, which was up 181287000.0% from 5386.03% recorded in Q1 2023.
  • Over the past 5 years, Pasithea Therapeutics' Operating Margin peaked at 5386.03% during Q1 2023, and registered a low of 19229.5% during Q2 2022.